Medicare Enrolled
Dr. Robert Luntz, MD
Urology Physician · Plainview, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Luntz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Luntz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Luntz
Dr. Robert Luntz is an urology physician in Plainview, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Luntz performed 16,119 Medicare services across 8,609 unique beneficiaries.
Between the years covered by Open Payments, Dr. Luntz received a total of $3,169 from 26 pharmaceutical and/or device companies across 124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Luntz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in NY
$3,169 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,119
Medicare services
Top 6% in NY for urology physician
8,609
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~806 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,100 | $18 | $49 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,996 | $10 | $48 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,887 | $108 | $441 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,764 | $3 | $10 |
| Leuprolide injectable, camcevi, 1 mg | 1,764 | $66 | $287 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,174 | $79 | $313 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
728 | $12 | $163 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
548 | $8 | $24 |
| PSA test (prostate cancer screening) | 470 | $18 | $55 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
422 | $54 | $209 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
411 | $8 | $9 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
343 | $8 | $26 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
245 | $230 | $971 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
203 | $8 | $24 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
201 | $8 | $24 |
| Injection, amikacin sulfate, 100 mg | 177 | $1 | $17 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
175 | $95 | $394 |
| Catheter specimen collection A procedure to collect a specimen using a catheter. This service is available in all places of service. |
175 | $8 | $9 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
151 | $19 | $76 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
108 | $18 | $55 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
99 | $34 | $227 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
86 | $13 | $49 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
67 | $127 | $495 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
67 | $72 | $270 |
| Complicated insertion of bladder tube | 66 | $141 | $535 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
64 | $75 | $590 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
63 | $33 | $121 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 63 | $141 | $758 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
59 | $352 | $1,305 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
49 | $189 | $691 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
49 | $665 | $5,784 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
40 | $268 | $1,305 |
| Antimicrobial drug detection test A laboratory test used to identify the presence of antibiotics, antifungals, or antivirals in a sample. |
40 | $5 | $14 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $143 | $579 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
35 | $119 | $446 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
33 | $47 | $172 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
31 | $233 | $936 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
23 | $22 | $273 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $51 | $198 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
17 | $25 | $77 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
17 | $80 | $290 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $76 | $333 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
14 | $8 | $25 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
11 | $233 | $851 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
11 | $411 | $1,435 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
30.8% medium
68.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,169
Total received (2018-2024)
Avg $453/year across 7 years
Top 42% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
124
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,169 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$636
2023
$978
2022
$570
2021
$540
2020
$191
2019
$109
2018
$146
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$188
Sumitomo Pharma America, Inc.
$149
PROCEPT BioRobotics Corporation
$147
Bayer Healthcare Pharmaceuticals Inc.
$75
Tolmar, Inc.
$32
Astellas Pharma US Inc
$26
Boston Scientific Corporation
$18
Top 3 companies account for 76.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$565
Dendreon Pharmaceuticals LLC
$344
NeoTract Inc.
$329
Sumitomo Pharma America, Inc.
$285
PROCEPT BioRobotics Corporation
$244
Astellas Pharma US Inc
$222
Bayer Healthcare Pharmaceuticals Inc.
$181
Myovant Sciences Inc.
$175
PFIZER INC.
$104
Teleflex LLC
$92
UROVANT SCIENCES INC
$91
TOLMAR Pharmaceuticals, Inc.
$85
Merck Sharp & Dohme LLC
$61
Bayer HealthCare Pharmaceuticals Inc.
$61
Endo Pharmaceuticals Inc.
$47
COLOPLAST CORP
$41
Amgen Inc.
$38
Tolmar, Inc.
$32
180 Medical, Inc.
$29
Progenics Pharmaceuticals, Inc.
$26
Myriad Genetic Laboratories, Inc.
$24
ABBVIE INC.
$22
Rochester Medical Corporation
$20
Coloplast Corp
$19
Boston Scientific Corporation
$18
ACCORD HEALTHCARE, INC.
$13
Top 3 companies account for 39.1% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · BOTOX · CAMCEVI · ELIGARD · ERLEADA · GEMTESA · GreenLight XPS · KEYTRUDA · MYRBETRIQ · Myrbetriq · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · SpeediCath · UROLIFT · UroLift · UroLift System · XGEVA · XIAFLEX · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
334
Per 100K population
24.1
County median income
$143,408
Nearest hospital
PLAINVIEW HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Luntz is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Luntz experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Luntz performed 2,100 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Luntz receive payments from pharmaceutical companies?
Yes. Dr. Luntz received a total of $3,169 from 26 companies across 124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Luntz's costs compare to other urology physicians in Plainview?
Dr. Luntz's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Luntz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Plainview
Browse urology physicians in Plainview ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology